Although previous studies had demonstrated that EPO reduces inflammation, cytokine production, fibrosis, and oxidative damage in the myocardium, chronic administration of EPO led to an increase in red blood cell mass and subsequent elevated stroke risk. The gene discussed is EPO; the disease is stroke disorder.